Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  22nd Century Group       

22ND CENTURY GROUP
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsCalendarCompanyFinancialsRevisions 
News SummaryMost relevantAll newsSector newsTweets

22nd Century : The Briefcase The Briefcase

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/14/2017 | 09:45am CET

22nd Century Group CEO

to speak at tobacco forum

22nd Century Group Inc., a plant biotechnology company with a production plant in Mocksville, said that Henry Sicignano III, its chief executive, will speak at today's Global Tobacco & Nicotine Forum in New York City.

Sicignano will participate on a panel discussing future next-generation products.

The forum is noted for its exchange of global ideas and information for tobacco technologies and products. Attendees to the forum include public health advocates, policymakers, scientists and industry executives.

22nd Century, based in Clarence, N.Y., bought the cigarette-manufacturing equipment of defunct Renegade Tobacco Co. in 2013 for $3.22 million in a bankruptcy proceeding.

Richard Craver

Triad HealthCare Network adds medical directors

Triad HealthCare Network said Wednesday it has added Drs. Beth Hodges and Rob Reade as medical directors to its primary care division.

The network is a partnership between area health-care providers and Cone Health.

Cone said the doctors will provide "a physician's perspective in developing the network's various quality and savings initiatives."

Hodges is a family medicine doctor at Hodges Family Practice in Asheville. Reade is a family medicine doctor at Eagle Family Medicine @ Triad. Both will continue seeing patients.

Richard Craver

Lexington Dialysis Center gets state OK for facility

Lexington Dialysis Center has received conditional approval from state health regulators for its certificate-of-need application.

The group has applied to spend $4.72 million on building a new facility on the same site at 233 Anna Lewis Drive.

The group is affiliated with Wake Forest Baptist Medical Center.

High Point pharmaceutical company plans IPO

Axium Pharmaceuticals Inc., based in High Point, has submitted a regulatory filing for a proposed initial public offering of its Class A common stock.

The company plans to sell 50 million shares, while shareholders plan to sell 45.13 million shares. There is no underwriter of the IPO.

The asking price is projected to be 10 cents a share, with potential gross proceeds of $9.51 million, including $5 million for use by the corporation.

Axium focuses on utilizing drug delivery innovations for developing improved novel formulations and alternative dosage forms of existing biologically active molecules. Product candidates address various pharmaceutical markets, including neurological disorderss, infectious diseases and diabetes.

Richard Craver

© © Copyright 2017, Winston-Salem Journal, Winston-Salem, NC, source Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on 22ND CENTURY GROUP
02/0822ND CENTURY : FDA Remains Firmly Committed to Nicotine Reduction in Cigarettes
AQ
02/0122ND CENTURY : to Present at BIO CEO & Investor Conference
BU
01/3122ND CENTURY : FDA Remains Firmly Committed to Nicotine Reduction in Cigarettes
BU
01/2922ND CENTURY : Global Cannabis Sales Projected to Grow
PR
01/22U.S. FDA's tobacco stance faces test with Philip Morris iQOS device
RE
01/1722ND CENTURY : Reality of Nicotine Reform Provides Long-Lasting Tailwinds for 22..
AQ
01/1622ND CENTURY GROUP INC : 22nd Century, How Manipulating Tobacco and Cannabis Pla..
AC
01/1122ND CENTURY : CBD Market Projected to Grow to New Highs
PR
01/0422ND CENTURY : Juan Sanchez Tamburrino, Ph.D. joins 22nd Century Group, Inc.
AQ
2017FRIDAY SECTOR LEADERS : Cigarettes & Tobacco, Beverages & Wineries
AQ
More news
News from SeekingAlpha
01/23Short seller takes aim at 22nd Century Group 
01/22260 MARIJUANA STOCKS : Equal-Weighted Portfolio Up Nearly 7% For The Week Ending.. 
01/21WEEK 4 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
01/1822nd Century Group builds on rally, up 11% 
01/16How To Find The Hottest Sectors For 2018 In The Coldest Part Of The Year 
Financials ($)
Sales 2017 16,7 M
EBIT 2017 -10,2 M
Net income 2017 -9,90 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 22,3x
Capi. / Sales 2018 17,4x
Capitalization 373 M
Chart 22ND CENTURY GROUP
Duration : Period :
22nd Century Group Technical Analysis Chart | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 11,5 $
Spread / Average Target 281%
EPS Revisions
Managers
NameTitle
Henry Sicignano President, Chief Executive Officer & Director
James W. Cornell Chairman
John T. Brodfuehrer CFO, Treasurer & Principal Accounting Officer
Juan Sanchez Tamburrino Vice President-Research & Development
Joseph Alexander Dunn Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
22ND CENTURY GROUP37.86%373
WASTE MANAGEMENT-4.29%36 974
REPUBLIC SERVICES-4.57%21 575
WASTE CONNECTIONS INC0.77%18 739
UMICORE19.58%12 757
SUEZ ENVIRONNEMENT-26.08%8 374